KURT WHEELER
CIK 1252525 · last filed 2019-02-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.82M
Companies
14
Total Filings
58
Lifetime Open-Market Net
-$103.85M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GMED | Director | 44,319 | $86.25 | $3.82M | -$90.17M | 13 | 2019-02-11 |
| Radius Health, Inc. (RDUS) Delisted | 2,459,804 | $30.00 | $73.79M | $0 | 1 | 2016-09-29 | |
| Oxford Immunotec Global PLC (OXFD) Delisted | 10%+ Owner | 2,237,377 | — | — | -$8.32M | 2 | 2015-06-17 |
| Pernix Sleep, Inc. (SOMX) Delisted | Director | 3,807,612 | — | — | -$1.82M | 14 | 2012-07-02 |
| ZOGENIX, INC. (ZGNX) Delisted | Director | 5,982,439 | $26.68 | $159.61M | $7.00M | 4 | 2012-06-06 |
| ReShape Weightloss Inc. (ETRM) Delisted | 1,669,753 | — | — | $0 | 1 | 2010-12-15 | |
| ARYx Therapeutics, Inc. (ARYX) Delisted | 10%+ Owner | — | — | — | $0 | 1 | 2010-10-04 |
| SENORX INC (SENO) Delisted | Director | 2,032,475 | — | — | -$2.77M | 6 | 2010-06-29 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | 2,208,961 | $15.00 | $33.13M | $0 | 1 | 2010-03-18 | |
| Pharmasset Inc (VRUS) Delisted | 10%+ Owner | 4,061 | — | — | -$2.19M | 1 | 2008-02-11 |
| HEMOSENSE INC (HEM) Delisted | Director | 4,003,119 | — | — | -$6.07M | 3 | 2007-11-07 |
| CRYOCOR INC (CRYO) Delisted | Director | 3,028,082 | — | — | $496.3K | 2 | 2007-05-15 |
| CORNERSTONE THERAPEUTICS INC (CRTX) Delisted | 3,846,328 | $1.95 | $7.50M | $0 | 1 | 2007-02-15 | |
| COTHERIX INC (CTRX) Delisted | 10%+ Owner | 0 | — | — | $0 | 1 | 2007-01-10 |
Recent Filings · Page 6 of 6
58 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-05-08 | Pernix Sleep, Inc. (SOMX) Delisted | Sell (S) | −3,800 | -$68.4K | EDGAR |
| 2007-05-03 | Pernix Sleep, Inc. (SOMX) Delisted | Sell (S) | −32,600 | -$589.1K | EDGAR |
| 2007-05-01 | Pernix Sleep, Inc. (SOMX) Delisted | Sell (S) | −62,600 | -$1.13M | EDGAR |
| 2007-04-25 | CRYOCOR INC (CRYO) Delisted | Buy (P) | +96,551 | $496.3K | EDGAR |
| 2007-04-03 | SENORX INC (SENO) Delisted | Conv (C) | +2,242,379 | $0 | EDGAR |
| 2007-03-16 | HEMOSENSE INC (HEM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-02-15 | CORNERSTONE THERAPEUTICS INC (CRTX) Delisted | Other (J) | +452 | $0 | EDGAR |
| 2007-01-10 | COTHERIX INC (CTRX) Delisted | Disp (D) | −35,725,550 | -$482.29M | EDGAR |
Showing 51–58 of 58
Prev
Page 6 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.